Alligator Bioscience gains orphan designation for mitazalimab
Mitazalimab is a monoclonal antibody that has been created to sensitize tumours to chemotherapy
Read More
Tag: mitazalimab
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
